Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6600645.pdf
Reference24 articles.
1. Alexopoulos CG, Rigatos G, Efremidis AP, Papacharalambous A, Alexopoulos A, Vassilomanolakis M, Patila E (1999) A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy. Hellenic Cooperative Interhospital Group in Oncology. Cancer Chemother Pharmacol 44: 253–258
2. Brodowicz T, Koestler WJ, Tomek S, Vaclavik I, Herscovici V, Wiltschke C, Steger GG, Zielinski CC (2000) Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer. Anticancer Drugs 11: 149–153
3. Brufman G, Colajori E, Ghilezan N, Lassus M, Martoni A, Perevodchikova N, Tosello C, Viaro D, Zielinski C (1997) Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group Ann Oncol 8: 155–162
4. Caballero GA, Aisman RK, Quebbeman EJ (1985) Long-term, ambulatory continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas. Cancer Treat Rep 69: 13–15
5. Cany L, Toulouse C, Ravaud A, Durand M, Mauriac L (1996) Vinorelbine/5-FU combination in metastatic breast cancer chemotherapy. A retrospective study of 63 cases. Eur J Cancer 32A: 370–371
Cited by 121 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Biomarkers and Treatment Strategies for Breast Cancer Recurrence;Current Drug Targets;2023-11
2. Dose‐dependent bidirectional pharmacological effects of vinorelbine‐based metronomic combination chemotherapy on tumor growth and metastasis and mechanisms in melanoma mouse model;Fundamental & Clinical Pharmacology;2023-07-17
3. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice;Critical Reviews in Oncology/Hematology;2020-09
4. Molecular docking analysis of docetaxel analogues as duel lipocalin 2 inhibitors;Bioinformation;2020-06-30
5. Hair disorders in patients with cancer;Journal of the American Academy of Dermatology;2019-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3